Development of mouse models for cystic fibrosis

Area of Science:

• Genetics
• Animal Models
• Disease Pathogenesis

Background:

• Gene targeting in embryonal stem cells enables creation of precise mouse models for inherited human diseases.
• Animal models are crucial for understanding disease mechanisms, genotype-phenotype relationships, and identifying genetic factors.
• Somatic gene therapy offers a promising approach for treating inherited diseases by correcting the underlying genetic defect.

Purpose of the Study:

• To highlight the utility of cystic fibrosis (CF) mouse models.
• To emphasize their role in clarifying disease pathogenesis and genotype-phenotype correlations.
• To underscore their importance as a platform for therapeutic intervention and testing.

Main Methods:

• Gene targeting in embryonal stem cells to create specific genetic mutations.
• Development of CF mouse models exhibiting characteristic electrophysiological defects.
• Modulation of Cftr gene levels in transgenic animals to study expression effects.

Main Results:

• CF mouse models accurately recapitulate key aspects of human cystic fibrosis.
• These models allow for monitoring the safety and efficacy of potential therapies.
• Studies on Cftr gene modulation provide insights into the required expression levels for clinical benefit.

Conclusions:

• Mouse models generated through gene targeting are invaluable for cystic fibrosis research.
• These models facilitate the investigation of disease mechanisms and the development of gene-based therapies.
• CF mouse models serve as critical preclinical tools for evaluating novel therapeutic strategies.